Takuya Mima
Counsel
Tokyo
- Language : Japanese, English
- Mail : takuya.mima@tkilaw.com
EXPERIENCE
- Dec. 2012-Dec.2015
- Kitahama Partners
- 2015
- Eli Lilly Japan K.K., Legal Div. (secondee)
- Jan. 2016-Dec.2024
- Nishimura & Asahi
- Aug. 2022-Dec.2023
- 2023, Okada Law Firm (Hong Kong) (secondee)
- Jan. 2024
- FUJIFILM Holdings Corporation, Intellectual Property Div. (secondee)
- Jan. 2025
- Joined Tokyo International Law Office
QUALIFICATION
- 2012 Japan (Daini Tokyo Bar Association)
- 2023 New York, U.S.
EDUCATION
- 2009
- LL.B., Kyoto University
- 2011
- J.D., Kyoto University Law School
- 2022
- LL.M., Business Law Certificate, Duke University School of Law
OTHER
- 2025 May Researcher, The Center for Interdisciplinary Studies of Law and Policy, Kyoto University (Research Group on Legal Issues in Healthcare Digital Transformation)
- 2025 Dec Joined “The Genotype Network”
Publication
- Oct. 2023
- Co-Author, “Indonesia: Indonesian Healthcare Sector: Notable Highlights for Foreign Investors”, Nishimura & Asahi Newsletter (online article), (in English and Japanese).
- Aug. 2023
- Co-Author, “Vietnam: Overview of the distribution rule and advertising regulations for medical devices”, Nishimura & Asahi Newsletter (online article), (in English and Japanese).
- Jul. 2023
- Co-Author, “Vietnam: Overview of the national rule for Software of Medical Devices (SaMD)”, Nishimura & Asahi Newsletter (online article), (in English and Japanese).
- 2020
- Co-Author, The International Comparative Legal Guide to: Pharmaceutical Advertising (Japan Chapter), Global Legal Group, 2020 edition (in English).
- Oct. 2019
- Author, “Revision to Patent Act in 2019”, International Law Office Newsletter (online article), (in English).
- 2019
- Co-Author, “IP in Business Transactions Multi-Jurisdictional Guide: Japan Chapter”, Practical Law Company (online article), 2019 edition (in English).
- 2019
- Co-Author, The International Comparative Legal Guide to: Pharmaceutical Advertising (Japan Chapter), Global Legal Group, 2019 edition (in English).
Seminar / Speaking Engagements
- 2026. March
- Regulatory Authorization in the Medical Device Business: Preparing for M&A and Investment — Fundamentals and Structural Considerations (TKI Seminar)
- 2023. July
- Fundamentals and Practice of U.S. Litigation — Strategic Management for Japanese Companies with a Focus on Discovery (Hosted by FRONTEO)
- 2023. July
- Practical Due Diligence in Life Sciences and Healthcare Businesses for M&A and Investment — Addressing Industry-Specific Regulations, R&D, and Market Practices (Hosted by Financial Management Forums, Inc.)